Skip to main content
Erschienen in: Clinical and Experimental Nephrology 2/2012

01.04.2012 | Case Report

Gitelman syndrome: novel mutation and long-term follow-up

verfasst von: Aditi Sinha, Petr Lněnička, Biswanath Basu, Ashima Gulati, Pankaj Hari, Arvind Bagga

Erschienen in: Clinical and Experimental Nephrology | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

We report a case of Gitelman syndrome presenting with fatigue, paresthesias, weakness of limbs and neck muscles since 2.5 years of age. Investigations showed hypokalemia and hypomagnesemia with urinary magnesium wasting. Genetic analysis revealed the presence of a novel homozygous mutation in the SLC12A3 gene (c.2879_2883+9ins14bp, p.Val 960 Glu fsx12). Management with potassium and magnesium supplements and spironolactone resulted in a significant improvement in symptoms. Over a follow-up of 11 years, the patient showed satisfactory growth and physical development.
Literatur
1.
Zurück zum Zitat Simon DB, Nelson-Williams C, Bia MJ, Ellison D, Karet FE, Molina AM, et al. Gitelman’s variant of Bartter’s syndrome, inherited hypokalemic alkalosis, is caused by mutations in the thiazide-sensitive Na–Cl cotransporter. Nat Genet. 1996;12:24–30.PubMedCrossRef Simon DB, Nelson-Williams C, Bia MJ, Ellison D, Karet FE, Molina AM, et al. Gitelman’s variant of Bartter’s syndrome, inherited hypokalemic alkalosis, is caused by mutations in the thiazide-sensitive Na–Cl cotransporter. Nat Genet. 1996;12:24–30.PubMedCrossRef
2.
Zurück zum Zitat Knoers NV. Inherited forms of renal hypomagnesemia: an update. Pediatr Nephrol. 2009;24:697–705.PubMedCrossRef Knoers NV. Inherited forms of renal hypomagnesemia: an update. Pediatr Nephrol. 2009;24:697–705.PubMedCrossRef
3.
Zurück zum Zitat Peters M, Jeck N, Reinalter S, Leonhardt A, Tonshoff B, Klaus GG, et al. Clinical presentation of genetically defined patients with hypokalemic salt-losing tubulopathies. Am J Med. 2002;112:183–90.PubMedCrossRef Peters M, Jeck N, Reinalter S, Leonhardt A, Tonshoff B, Klaus GG, et al. Clinical presentation of genetically defined patients with hypokalemic salt-losing tubulopathies. Am J Med. 2002;112:183–90.PubMedCrossRef
4.
Zurück zum Zitat Bettinelli A, Metta MG, Perini A, Basilico E, Santeramo C. Long-term follow-up of a patient with Gitelman’s syndrome. Pediatr Nephrol. 1993;7:67–8.PubMedCrossRef Bettinelli A, Metta MG, Perini A, Basilico E, Santeramo C. Long-term follow-up of a patient with Gitelman’s syndrome. Pediatr Nephrol. 1993;7:67–8.PubMedCrossRef
5.
Zurück zum Zitat Herrero-Morín JD, Rodríguez J, Coto E, Gil-Peña H, Alvarez V, Espinosa L, et al. Gitelman syndrome in Gypsy pediatric patients carrying the same intron 9 + 1 G>T mutation. Clinical features and impact on quality of life. Nephrol Dial Transpl. 2011;26:151–5.CrossRef Herrero-Morín JD, Rodríguez J, Coto E, Gil-Peña H, Alvarez V, Espinosa L, et al. Gitelman syndrome in Gypsy pediatric patients carrying the same intron 9 + 1 G>T mutation. Clinical features and impact on quality of life. Nephrol Dial Transpl. 2011;26:151–5.CrossRef
6.
Zurück zum Zitat Conti G, Vitale A, Tedeschi S, Syrén ML, Pantano R, Chimenz R, et al. Hypokalaemia and failure to thrive: report of a misleading onset. J Paediatr Child Health. 2010;46:276–7.PubMedCrossRef Conti G, Vitale A, Tedeschi S, Syrén ML, Pantano R, Chimenz R, et al. Hypokalaemia and failure to thrive: report of a misleading onset. J Paediatr Child Health. 2010;46:276–7.PubMedCrossRef
7.
Zurück zum Zitat Pachulski RT, Lopez F, Sharaf R. Gitelman’s not-so-benign syndrome. N Engl J Med. 2005;353:850–1.PubMedCrossRef Pachulski RT, Lopez F, Sharaf R. Gitelman’s not-so-benign syndrome. N Engl J Med. 2005;353:850–1.PubMedCrossRef
9.
Zurück zum Zitat Colussi G, Bettinelli A, Tedeshi S, de Ferrari ME, Syren ML, Borsa N, et al. A thiazide test for the diagnosis of renal tubular hypokalemic disorders. Clin J Am Soc Nephrol. 2007;2:454–60.PubMedCrossRef Colussi G, Bettinelli A, Tedeshi S, de Ferrari ME, Syren ML, Borsa N, et al. A thiazide test for the diagnosis of renal tubular hypokalemic disorders. Clin J Am Soc Nephrol. 2007;2:454–60.PubMedCrossRef
10.
Zurück zum Zitat Riveira-Munoz E, Chang Q, Godefroid N, Hoenderop JG, Bindels RJ, Dahan K, et al. for the Belgian Network for the Study of Gitelman syndrome. Transcriptional and functional analyses of SLC12A3 mutations: new clues for the pathogenesis of Gitelman syndrome. J Am Soc Nephrol. 2007;18:1271–83. Riveira-Munoz E, Chang Q, Godefroid N, Hoenderop JG, Bindels RJ, Dahan K, et al. for the Belgian Network for the Study of Gitelman syndrome. Transcriptional and functional analyses of SLC12A3 mutations: new clues for the pathogenesis of Gitelman syndrome. J Am Soc Nephrol. 2007;18:1271–83.
11.
Zurück zum Zitat Takeuchi K, Kure S, Kato T, Taniyama Y, Takahashi N, Ikeda Y, et al. Association of a mutation in thiazide-sensitive Na–Cl cotransporter with familial Gitelman syndrome. J Clin Endocrinol Metab. 1996;81:4496–9.PubMedCrossRef Takeuchi K, Kure S, Kato T, Taniyama Y, Takahashi N, Ikeda Y, et al. Association of a mutation in thiazide-sensitive Na–Cl cotransporter with familial Gitelman syndrome. J Clin Endocrinol Metab. 1996;81:4496–9.PubMedCrossRef
12.
Zurück zum Zitat Lemmink HH, Knoers NV, Karolyi L, van Dijk H, Niaudet P, Antignac C, et al. Novel mutations in the thiazide-sensitive NaCl cotransporter gene in patients with Gitelman syndrome with predominant localization to the C-terminal domain. Kidney Int. 1998;54:720–30.PubMedCrossRef Lemmink HH, Knoers NV, Karolyi L, van Dijk H, Niaudet P, Antignac C, et al. Novel mutations in the thiazide-sensitive NaCl cotransporter gene in patients with Gitelman syndrome with predominant localization to the C-terminal domain. Kidney Int. 1998;54:720–30.PubMedCrossRef
Metadaten
Titel
Gitelman syndrome: novel mutation and long-term follow-up
verfasst von
Aditi Sinha
Petr Lněnička
Biswanath Basu
Ashima Gulati
Pankaj Hari
Arvind Bagga
Publikationsdatum
01.04.2012
Verlag
Springer Japan
Erschienen in
Clinical and Experimental Nephrology / Ausgabe 2/2012
Print ISSN: 1342-1751
Elektronische ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-011-0542-x

Weitere Artikel der Ausgabe 2/2012

Clinical and Experimental Nephrology 2/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.